# emole

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/emole

- Industry: Software
- Headquarters: Tokyo, Japan
- Website: https://emole.co.jp
- Total disclosed funding: $0.4M
- Latest round: Series A (Mar 28, 2025)
- Investors on record: 8

## About

Based in Japan, emole Inc. specializes in developing advanced solutions for the digital healthcare and wellness sectors, primarily focusing on enhancing user engagement and improving overall health outcomes.Founded in 2018 and headquartered in Tokyo, Japan, emole Inc. provides innovative health management solutions. In October 2025, emole Inc. raised JPY 690 million in venture debt funding from new investors Siiibo Securities Co., Ltd., Shizuoka Bank, Japan Finance Corporation, Higashi-Nippon Bank, Hokkoku Bank, Mizuho Bank, and Yamanashi Chuo Bank. Individual investors also participated in this round.

emole Inc. specializes in innovative solutions for the digital healthcare and wellness sectors, focusing on products that enhance user engagement and improve health outcomes. Their core offerings include a comprehensive health management platform, which integrates wearable technology and mobile applications to monitor vital health metrics and provide actionable insights for users. Released recently, this platform caters to both individual consumers and healthcare providers, aiming to streamline health management processes and promote proactive health behaviors. The company serves a diverse client base that includes hospitals, clinics, and fitness centers, particularly targeting markets in East Asia and North America. Through these products, emole seeks to address critical challenges in personal health tracking and data analytics. emole Inc. generates revenue primarily through a subscription-based model for its health management platform, offering various pricing tiers tailored to different user needs, including both individual plans and enterprise solutions for healthcare providers. Transactions are structured around annual and monthly subscriptions, where clients gain access to the platform's features, including real-time health monitoring and personalized health recommendations. In addition to subscriptions, the company may engage in partnerships with healthcare organizations, facilitating broader access to their technology across various healthcare settings. Their flagship product, which integrates seamlessly with wearable devices, represents a significant portion of their revenue stream, capitalizing on the growing demand for digital health solutions.

The company plans to use the October 2025 funding to expand its content offerings, invest in marketing globally, and develop its platform.

## Funding rounds

- Series A, Mar 28, 2025 — Samurai Incubate, Sega Sammy Holdings, Dentsu Ventures, D4V, Angel Bridge, Aozora Corporate Investment, Hakuhodo DY Ventures, Chiba Dojo
- Seed, Aug 4, 2022, $0.4M — Samurai Incubate, Chiba Dojo

## Investors

- Samurai Incubate (https://capitalatlas.ai/funds/samurai-incubate) — Seed, Series A
- Chiba Dojo (https://capitalatlas.ai/funds/chiba-dojo) — Seed, Series A
- Sega Sammy Holdings — Series A
- Dentsu Ventures (https://capitalatlas.ai/funds/dentsu-ventures) — Series A
- D4V (https://capitalatlas.ai/funds/d4v) — Series A
- Angel Bridge (https://capitalatlas.ai/funds/angel-bridge) — Series A
- Aozora Corporate Investment (https://capitalatlas.ai/funds/aozora-corporate-investment) — Series A
- Hakuhodo DY Ventures (https://capitalatlas.ai/funds/hakuhodo-dy-ventures) — Series A